ANL 11.28 Increased By ▲ 1.00 (9.73%)
ASC 9.50 Increased By ▲ 0.41 (4.51%)
ASL 11.24 Increased By ▲ 0.25 (2.27%)
AVN 78.01 Increased By ▲ 0.41 (0.53%)
BOP 5.51 Increased By ▲ 0.11 (2.04%)
CNERGY 5.41 Increased By ▲ 0.08 (1.5%)
FFL 6.76 Increased By ▲ 0.16 (2.42%)
FNEL 5.91 Increased By ▲ 0.06 (1.03%)
GGGL 11.30 Increased By ▲ 0.21 (1.89%)
GGL 16.78 Increased By ▲ 0.25 (1.51%)
GTECH 8.99 Increased By ▲ 0.58 (6.9%)
HUMNL 7.20 Increased By ▲ 0.06 (0.84%)
KEL 2.96 Decreased By ▼ -0.04 (-1.33%)
KOSM 3.46 Increased By ▲ 0.25 (7.79%)
MLCF 27.15 Increased By ▲ 0.15 (0.56%)
PACE 3.10 Increased By ▲ 0.10 (3.33%)
PIBTL 6.11 Increased By ▲ 0.17 (2.86%)
PRL 18.06 Increased By ▲ 0.16 (0.89%)
PTC 7.08 Increased By ▲ 0.11 (1.58%)
SILK 1.19 Increased By ▲ 0.02 (1.71%)
SNGP 34.75 Increased By ▲ 0.47 (1.37%)
TELE 10.94 Increased By ▲ 0.13 (1.2%)
TPL 9.40 Increased By ▲ 0.32 (3.52%)
TPLP 20.49 Increased By ▲ 0.34 (1.69%)
TREET 29.40 Increased By ▲ 0.25 (0.86%)
TRG 77.50 Increased By ▲ 0.39 (0.51%)
UNITY 20.36 Increased By ▲ 0.31 (1.55%)
WAVES 12.80 No Change ▼ 0.00 (0%)
WTL 1.37 Increased By ▲ 0.04 (3.01%)
YOUW 5.51 Increased By ▲ 0.52 (10.42%)
BR100 4,137 Increased By 36.3 (0.88%)
BR30 15,237 Increased By 211.2 (1.41%)
KSE100 41,734 Increased By 192.7 (0.46%)
KSE30 15,891 Increased By 85.6 (0.54%)

AstraZeneca vaccines

AstraZeneca says EU loses legal bid for more vaccine supplies by end-June
World

AstraZeneca says EU loses legal bid for more vaccine supplies by end-June

  • The supply cuts delayed the EU's vaccination drive in the first quarter of the year, when the bloc had initially bet on AstraZeneca to deliver the largest volume of its shots.
  • The court said in a statement that AstraZeneca must deliver 15 million doses by July 26, another 20 million by Aug. 23 and another 15 million by Sept. 27, for a total of 50 million doses.
Published 18 Jun, 2021 06:10pm
Britain approves J&J COVID-19 vaccine for use
World

Britain approves J&J COVID-19 vaccine for use

  • Britain also cut its order for the single-dose shot, also known as J&J unit Janssen's vaccine, amid issues with the company's supply chain and reports of rare blood clots.
  • J&J's vaccine is already approved in the United States and European Union, where reports of rare blood clots are being reviewed.
Published 28 May, 2021 05:36pm
Japan health panel approves Moderna, AstraZeneca COVID-19 vaccines
World

Japan health panel approves Moderna, AstraZeneca COVID-19 vaccines

  • The recommendations by a health ministry panel precede official approval by the government on Friday, national broadcaster NHK reported.
  • Supplies of the Moderna doses have already been imported and are planned for use at mass vaccination centres in Tokyo and Osaka from next week.
Published 20 May, 2021 07:37pm
South Korea suspends AstraZeneca shots for people under 60 amid European review
World

South Korea suspends AstraZeneca shots for people under 60 amid European review

  • The European Medical Agency (EMA) is due to announce the results of a review on whether some cases of blood clotting in adults may be linked to the AstraZeneca shot.
  • South Korea's food and drug safety ministry said on Wednesday it had granted final approval for Johnson & Johnson's (J&J) vaccine after a panel of experts ruled the single-dose shot was safe and effective.
Published 07 Apr, 2021 07:12pm
Ukraine approves Chinese vaccine as COVID-19 cases hit new record high
World

Ukraine approves Chinese vaccine as COVID-19 cases hit new record high

  • Ukraine received its first batch of 215,000 Sinovac doses in March to boost its vaccination programme, which has lagged behind many other European countries and it has so far relied on a single batch of AstraZeneca vaccines from India.
  • "The vaccines of the Chinese company Sinovac Biotech can be trusted," it said.
Published 03 Apr, 2021 06:41pm
Netherlands halts use of AstraZeneca vaccine for people under 60
World

Netherlands halts use of AstraZeneca vaccine for people under 60

  • The decision was made following new reports from medicine monitoring agency Lareb and discussions with health authorities, a Health Ministry statement said.
  • "Authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," it said.
Updated 02 Apr, 2021 09:06pm